Kevin Lind - Longboard Pharmaceuticals CEO and President
| LBPHDelisted Stock | USD 59.98 0.00 0.00% |
Insider
Kevin Lind is CEO and President of Longboard Pharmaceuticals
| Age | 48 |
| Phone | 858 789 9283 |
| Web | https://www.longboardpharma.com |
Kevin Lind Latest Insider Activity
Tracking and analyzing the buying and selling activities of Kevin Lind against Longboard Pharmaceuticals stock is an integral part of due diligence when investing in Longboard Pharmaceuticals. Kevin Lind insider activity provides valuable insight into whether Longboard Pharmaceuticals is net buyers or sellers over its current business cycle. Note, Longboard Pharmaceuticals insiders must abide by specific rules, including filing SEC forms every time they buy or sell Longboard Pharmaceuticals'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Kevin Lind over a month ago Disposition of 12808 shares by Kevin Lind of Longboard Pharmaceuticals at 3.1232 subject to Rule 16b-3 | ||
Kevin Lind over a month ago Acquisition by Kevin Lind of 22000 shares of Longboard Pharmaceuticals subject to Rule 16b-3 |
Longboard Pharmaceuticals Management Efficiency
The company has return on total asset (ROA) of (0.3072) % which means that it has lost $0.3072 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4666) %, meaning that it created substantial loss on money invested by shareholders. Longboard Pharmaceuticals' management efficiency ratios could be used to measure how well Longboard Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Longboard Pharmaceuticals currently holds 475 K in liabilities with Debt to Equity (D/E) ratio of 0.0, which may suggest the company is not taking enough advantage from borrowing. Longboard Pharmaceuticals has a current ratio of 11.71, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Longboard Pharmaceuticals' use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Silvia Buonamici | Monte Rosa Therapeutics | N/A | |
| CPA CPA | Stoke Therapeutics | 63 | |
| Adrian Krainer | Stoke Therapeutics | 65 | |
| Michael MBA | Champions Oncology | N/A | |
| Joo MD | Design Therapeutics | 61 | |
| MHROD SHRMSCP | Assembly Biosciences | N/A | |
| Dawn Kalmar | Stoke Therapeutics | 46 | |
| Maria Mancini | Champions Oncology | N/A | |
| W Vernon | Nuvation Bio | 65 | |
| Kenneth Cundy | Anebulo Pharmaceuticals | 65 | |
| Scott Anderson | Anebulo Pharmaceuticals | N/A | |
| Badreddin Edris | Edgewise Therapeutics | 37 | |
| Yuichi MD | MediciNova | 74 | |
| Jason CPA | MediciNova | 46 | |
| Julie CPA | Design Therapeutics | N/A | |
| Lieping MD | NextCure | 67 | |
| Sergey Yurasov | Nuvation Bio | 51 | |
| Seth Lewis | Molecular Partners AG | N/A | |
| Solomon Langermann | NextCure | 64 | |
| Christopher JD | Sensei Biotherapeutics | N/A | |
| Tharaknath Rao | Assembly Biosciences | N/A | |
Management Performance
| Return On Equity | -0.47 | ||||
| Return On Asset | -0.31 |
Longboard Pharmaceuticals Leadership Team
Elected by the shareholders, the Longboard Pharmaceuticals' board of directors comprises two types of representatives: Longboard Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Longboard. The board's role is to monitor Longboard Pharmaceuticals' management team and ensure that shareholders' interests are well served. Longboard Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Longboard Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Dewey McLin, VP Affairs | ||
| Jodi Parsons, VP Affairs | ||
| Chadwick MPH, Executive Operations | ||
| Steven JD, Head Counsel | ||
| Randall MD, Executive Officer | ||
| Nuggehally Srinivas, VP Pharmacometrics | ||
| Megan Knight, Head Relations | ||
| Anne Danks, VP Development | ||
| Marco Peters, VP Science | ||
| Kevin Lind, CEO and President | ||
| Gus Cardenas, VP Assurance |
Longboard Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Longboard Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.47 | ||||
| Return On Asset | -0.31 | ||||
| Current Valuation | 2.06 B | ||||
| Shares Outstanding | 34.44 M | ||||
| Shares Owned By Insiders | 1.19 % | ||||
| Shares Owned By Institutions | 98.81 % | ||||
| Number Of Shares Shorted | 1.93 M | ||||
| Price To Book | 8.51 X | ||||
| EBITDA | (56.75 M) | ||||
| Net Income | (54.42 M) |
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Longboard Stock
If you are still planning to invest in Longboard Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Longboard Pharmaceuticals' history and understand the potential risks before investing.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |